KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vir Biotechnology (VIR) Revenue: 2018-2025

Historic Revenue for Vir Biotechnology (VIR) over the last 7 years, with Sep 2025 value amounting to $240,000.

  • Vir Biotechnology's Revenue fell 89.92% to $240,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $16.9 million, marking a year-over-year decrease of 78.55%. This contributed to the annual value of $74.2 million for FY2024, which is 13.90% down from last year.
  • Vir Biotechnology's Revenue amounted to $240,000 in Q3 2025, which was down 80.23% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, Vir Biotechnology's Revenue ranged from a high of $1.2 billion in Q1 2022 and a low of $240,000 during Q3 2025.
  • Over the past 3 years, Vir Biotechnology's median Revenue value was $3.1 million (recorded in 2024), while the average stood at $15.0 million.
  • In the last 5 years, Vir Biotechnology's Revenue skyrocketed by 62,271.41% in 2022 and then tumbled by 99.30% in 2023.
  • Vir Biotechnology's Revenue (Quarterly) stood at $812.7 million in 2021, then slumped by 93.92% to $49.4 million in 2022, then crashed by 66.03% to $16.8 million in 2023, then decreased by 26.29% to $12.4 million in 2024, then tumbled by 89.92% to $240,000 in 2025.
  • Its Revenue was $240,000 in Q3 2025, compared to $1.2 million in Q2 2025 and $3.0 million in Q1 2025.